Dow Up 0.08% Nasdaq Down 0.30%

Neogenomics Inc. (NEO)

-NasdaqCM
5.57 0.12(2.20%) Sep 19, 4:00PM EDT
Prev Close:5.45
Open:5.45
Bid:3.96 x 200
Ask:N/A
1y Target Est:7.00
Beta:1.33
Next Earnings Date:N/A
Day's Range:5.38 - 5.65
52wk Range:2.50 - 6.10
Volume:292,373
Avg Vol (3m):654,553
Market Cap:279.47M
P/E (ttm):135.85
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NEOUp 2.20%279.47M
LH9.01B
MYGN2.73B

Key Statistics

Forward P/E (1 yr):69.62
P/S (ttm):3.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.01
Quarterly EPS Est (Sep-14) :-0.01
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):27.85

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback